Rapport Therapeutics, Inc. (RAPP)
NASDAQ: RAPP · Real-Time Price · USD
40.21
-2.41 (-5.65%)
Jul 20, 2026, 4:00 PM EDT - Market closed
Rapport Therapeutics Market Cap
Rapport Therapeutics has a market cap or net worth of $1.92 billion as of July 21, 2026. Its market cap has increased by 258.93% in one year.
Market Cap
1.92B
Enterprise Value
1.46B
1-Year Change
258.93%
Ranking
Category
Stock Price
$40.21
ChartMarket Cap Chart
Since the IPO on June 7, 2024, Rapport Therapeutics's market cap has increased from $601.40M to $1.92B, an increase of 219.77%. That is a compound annual growth rate of 73.13%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 20, 2026 | 1.92B | 32.99% |
| Dec 31, 2025 | 1.45B | 122.86% |
| Dec 31, 2024 | 648.87M | 7.89% |
| Jun 7, 2024 | 601.40M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Monte Rosa Therapeutics | 2.07B |
| Aurinia Pharmaceuticals | 2.05B |
| Syndax Pharmaceuticals | 2.02B |
| Nuvation Bio | 2.02B |
| ADMA Biologics | 2.02B |
| Viridian Therapeutics | 1.99B |
| AbCellera Biologics | 1.97B |
| GH Research | 1.97B |